profits News
Most Popular profits Story
Lilly hunkers down for lean years with salary freeze
Eli Lilly ($LLY), languishing in the doldrums of its long-expected "Years YZ," has frozen the salaries of many of its staffers, including those of top management. As Pharmalot reports, the company Read more...
Latest Headlines
- February 6, 2012
- January 21, 2011
- July 29, 2010
- February 17, 2010
- February 16, 2010
- February 16, 2010
- February 10, 2010
- February 4, 2010
- February 3, 2010
- December 22, 2009
- July 15, 2009
- July 1, 2009
- October 22, 2008
- October 15, 2008
- May 21, 2008
- April 30, 2008
- April 3, 2008
- February 14, 2008
- February 12, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
